311 related articles for article (PubMed ID: 24369337)
1. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.
Yen TW; Laud PW; Sparapani RA; Nattinger AB
JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337
[TBL] [Abstract][Full Text] [Related]
2. The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.
Yen TWF; Li J; Sparapani RA; Laud PW; Nattinger AB
Medicine (Baltimore); 2016 Aug; 95(31):e4392. PubMed ID: 27495053
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer.
Yen TWF; Laud PW; Pezzin LE; McGinley EL; Wozniak E; Sparapani R; Nattinger AB
Med Care; 2018 Jan; 56(1):78-84. PubMed ID: 29087982
[TBL] [Abstract][Full Text] [Related]
5. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Mann JM; Wu X; Christos P; Nagar H
Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
[TBL] [Abstract][Full Text] [Related]
6. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
9. Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer.
Aubry S; Strassle PD; Maduekwe U; Downs-Canner S
J Surg Res; 2020 Dec; 256():13-22. PubMed ID: 32679224
[TBL] [Abstract][Full Text] [Related]
10. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer.
Yen TW; Fan X; Sparapani R; Laud PW; Walker AP; Nattinger AB
Ann Surg Oncol; 2009 Apr; 16(4):979-88. PubMed ID: 19194754
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
12. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
[TBL] [Abstract][Full Text] [Related]
13. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
[TBL] [Abstract][Full Text] [Related]
14. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
15. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
16. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
[TBL] [Abstract][Full Text] [Related]
17. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.
Schwartz GF
Breast J; 2004; 10(2):85-8. PubMed ID: 15009032
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
